Burning Rock Biotech (BNR) Gains from Sales and Divestitures (2021 - 2022)
Burning Rock Biotech (BNR) recorded quarterly Gains from Sales and Divestitures of $166000.0 in Q2 2022, up 8151.22% quarter-over-quarter from $2011.8 in Q2 2021, and up 8151.22% on a YoY basis from $2011.8 in Q2 2021.
Burning Rock Biotech (BNR) Gains from Sales and Divestitures (2021 - 2022) Analysis & Trends
Burning Rock Biotech's Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $166000.0 for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Burning Rock Biotech | 20.35 Mn | -47.48 Mn | 14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 166,000.00 |
| Jun 30, 2022 | 166,000.00 |
| Jun 30, 2021 | 2,011.82 |
| Jun 30, 2021 | 2,011.82 |